淋球菌奈瑟菌肝素结合抗原在微菌落形成、血清抵抗及上皮细胞黏附中的作用
本研究探究淋病奈瑟菌的奈瑟菌肝素结合抗原(NHBA),确认其结合肝素等多种聚糖,并鉴定其与淋球菌及宿主细胞的相互作用。淋球菌nhba突变体较野生株细胞聚集和微菌落形成减少,人血清中存活率降低,对人宫颈和尿道上皮细胞黏附减少。提示NHBA参与淋球菌定植与存活多个环节,或为新型抗菌或疫苗靶点。
要点
- 淋球菌NHBA可结合肝素等多种聚糖,并介导与淋球菌及宿主细胞相互作用。
- nhba突变体细胞聚集和微菌落形成减少,人血清存活率降低。
- nhba突变体对人宫颈和尿道上皮细胞黏附减少,NHBA或为抗菌/疫苗靶点。
核心结论
- 淋球菌NHBA参与微菌落形成、血清抵抗及上皮细胞黏附,可能成为新型抗菌或疫苗靶点。
研究设计与样本
- 基础研究:比较淋球菌nhba突变体与野生株的聚糖结合、细胞相互作用、细胞聚集、微菌落形成、人血清存活及上皮细胞黏附。
主要发现
- NHBA可结合肝素等多种聚糖,并与淋球菌及宿主细胞发生相互作用。
- nhba突变体较野生株细胞聚集和微菌落形成减少。
- nhba突变体较野生株人血清中存活减少。
- nhba突变体较野生株对人宫颈和尿道上皮细胞黏附减少。
临床怎么用
- NHBA参与淋球菌定植与存活,可作为抗菌或疫苗研发的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The sexually transmitted infection gonorrhoea is on the rise worldwide and an increased understanding of the mechanisms of colonization and pathogenesis of Neisseria gonorrhoeae is required to aid development of new treatment and prevention strategies. In the current study, we investigate the neisserial heparin-binding antigen (NHBA) of N. gonorrhoeae and confirm its role in binding to several glycans, including heparin, and identify interactions of NHBA with both gonococcal and host cells. Furthermore, we report that a gonococcal nhba mutant displays decreased cell aggregation and microcolony formation, as well as reduced survival in human serum and reduced adherence to human cervical and urethral epithelial cells, relative to the wild-type strain. These data indicate that the gonococcal NHBA contributes to several aspects of the colonization and survival of N. gonorrhoeae and may be a target for new antimicrobial or vaccines.
引用
- Semchenko EA, Mubaiwa TD, Day CJ, et al. Role of the Gonococcal Neisserial Heparin Binding Antigen in Microcolony Formation, and Serum Resistance and Adherence to Epithelial Cells. J Infect Dis. 2020. PMID: 31781772. doi:10.1093/infdis/jiz628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。